We saw my Dad's MO on 5/23. Over the course of 4 weeks my dad's PSA moved from 1.46 to 2.14, He said we need to be on Zytiga for three months before we can deem it a failure, but just like Xtandi, it appears my dad had limited help with it. We have talked about the next steps, chemo and pluvicto. My dad has widespread bone mets and was very advanced at the initial diagnosis. His MO feels really strongly that chemo is not a great option for my dad with his frailty and even has concerns that going on it could not the performance status of my dad down which would lead to a problem getting Pluvicto. He has had three patients who were approved to go straight to Pluvicto bypassing chemo. The goal is to retest PSA at six weeks, do a petscan, and decide the next steps. He mentioned the possible need to do a biopsy somewhere. However, I remember when my father broke his hip 18 months ago, they did a biopsy of the tissue all around and inside the hip. The biopsy stated the following:The neoplasmdemonstrates moderate NKX3.1 (prostate marker) and is negative for PSA, CK7, CK20
and CDX2. Based on the histomorphology coupled with NKX3.1 positivity, the findings
are consistent with metastatic prostate carcinoma.
Does this mean anything for treatment options?
Thanks!